Michael Linnebacher

Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.

An in vitro system for the determination of individualized immunosuppression.

Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.

Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).

Cryopreservation of human colorectal carcinomas prior to xenografting.

Bacterial immunotherapy of gastrointestinal tumors.

Tumor-infiltrating B cells come into vogue.

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Optimizing the process of nucleofection for professional antigen presenting cells.

Generation of Xenotransplants from Human Cancer Biopsies to Assess Anti-cancer Activities of HDACi.

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.

Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line.

Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.

Colorectal cancer vaccines: Tumor-associated antigens neoantigens.

Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M.

NSG mice as hosts for oncological precision medicine.

Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research.

Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico Models.

Mouse models of colorectal cancer: Past, present and future perspectives.

Patient-individual cancer cell lines and tissue analysis delivers no evidence of sequences from DNA viruses in colorectal cancer cells.

Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells.

CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens.